Literature DB >> 20414316

Hypertension: spironolactone and resistant hypertension.

Jonathan S Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20414316     DOI： 10.1038/nrendo.2010.26

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent.

Authors:  Deirdre A Lane; D Gareth Beevers
Journal:  J Hypertens       Date:  2007-12       Impact factor: 4.844

2.  Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk.

Authors:  C Ferri; C Bellini; G Desideri; M Valenti; G De Mattia; A Santucci; N K Hollenberg; G H Williams
Journal:  Diabetes       Date:  1999-08       Impact factor: 9.461

3.  Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

Authors:  Eduardo Pimenta; Krishna K Gaddam; Suzanne Oparil; Inmaculada Aban; Saima Husain; Louis J Dell'Italia; David A Calhoun
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

4.  Efficacy of low-dose spironolactone in subjects with resistant hypertension.

Authors:  Mari Konishi Nishizaka; Mohammad Amin Zaman; David A Calhoun
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

5.  Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.

Authors:  Rhonda Bentley-Lewis; Gail K Adler; Todd Perlstein; Ellen W Seely; Paul N Hopkins; Gordon H Williams; Rajesh Garg
Journal:  J Clin Endocrinol Metab       Date:  2007-08-28       Impact factor: 5.958

6.  Efficacy and tolerance of spironolactone in essential hypertension.

Authors:  X Jeunemaitre; G Chatellier; C Kreft-Jais; A Charru; C DeVries; P F Plouin; P Corvol; J Menard
Journal:  Am J Cardiol       Date:  1987-10-01       Impact factor: 2.778

7.  Efficacy of spironolactone therapy in patients with true resistant hypertension.

Authors:  Fabio de Souza; Elizabeth Muxfeldt; Roberto Fiszman; Gil Salles
Journal:  Hypertension       Date:  2009-10-26       Impact factor: 10.190

8.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190
  8 in total
  1 in total

1.  Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.

Authors:  Emmanuel S Buys; Michael J Raher; Andrew Kirby; Mohd Shahid; Shahid Mohd; David M Baron; Sarah R Hayton; Laurel T Tainsh; Patrick Y Sips; Kristen M Rauwerdink; Qingshang Yan; Robert E T Tainsh; Hannah R Shakartzi; Christine Stevens; Kelly Decaluwé; Maria da Gloria Rodrigues-Machado; Rajeev Malhotra; Johan Van de Voorde; Tong Wang; Peter Brouckaert; Mark J Daly; Kenneth D Bloch
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.